- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00578032
Reconstructive Surgery For Head And Neck Cancer Patients
October 17, 2017 updated by: Memorial Sloan Kettering Cancer Center
Reconstructive Surgery For Head And Neck Cancer Patients: A Prospective Analysis Of Quality Of Life And Symptom Relief
The goal of this study is to better understand the changes in symptoms and overall quality of life after head and neck surgery and reconstruction.
"Quality of Life" means how you feel about your life as a result of your disease and its treatment.
Learning about changes in patients' quality of life will help doctors and future patients make more informed treatment decisions.
Study Overview
Status
Completed
Conditions
Detailed Description
This prospective, longitudinal study will evaluate patient-reported quality of life and symptomatology immediately prior to and for up to one year following surgical resection and reconstruction head and neck malignancies.Patients with head and neck malignancies that require simultaneous surgical resection and reconstruction of the ablative defect will be eligible to participate.Quality of life and symptom relief will be evaluated by both domain and disease specific questionnaires at four time points: pre-operatively, and 3 months (±1 month), 6 months (±1), and 9 months (-1 and +3) post-operatively.
These assessment points represent clinically significant events in patients' post-operative course following head and neck surgery.
Studies have shown that quality of life decreases significantly at three months after surgery but then reapproaches baseline levels around one year (1).
Pre-operative responses will serve as the baseline for comparison.
Study Type
Observational
Enrollment (Actual)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan-Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with head and and neck malignancies hat require simultaneous surgical resection and reconstruction of the ablative defect will be eligible to participate.
Description
Inclusion Criteria:
- Patients undergoing surgical resection and reconstruction for every stage head and neck malignancies at Memorial Sloan-Kettering Cancer Center.
- Patients at least 21 years of age
Exclusion Criteria:
- Patients who are less than 21 years old
- Patients who do not speak the English language
- Patients who are unable to comprehend the content of the questionnaires due to psychiatric disorders or cognitive impairment
- Patients who cannot complete the pre-operative questionnaires during consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
Patients with head and neck malignancies that require simultaneous surgical resection and reconstruction of the ablative defect will be eligible to participate.
|
All patients will complete the predefined questionnaires at the following four time points along the course of their care: preoperative clinic visit, and 3 months (±1 month), 6 months (±1), and 9 months (1 and +3) post-operatively.
Completion of the questionnaires should take approximately 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To describe overall pt-reported health-related QOL and cancer related symptoms pre-operatively and at 3, 6 and 9 mos following surgical resection and reconstruction for head & neck malignancies
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To describe changes in patient-reported health-related quality of life and cancer-related symptoms within 9 or 12 months following surgical resection and reconstruction.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Andrea Pusaic, MD, MHS, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
October 1, 2017
Study Registration Dates
First Submitted
December 18, 2007
First Submitted That Met QC Criteria
December 19, 2007
First Posted (Estimate)
December 20, 2007
Study Record Updates
Last Update Posted (Actual)
October 19, 2017
Last Update Submitted That Met QC Criteria
October 17, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-150
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Stage Head and Neck Cancer
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Head and Neck CancerChina
-
Kuwait Cancer Control CenterRecruitingLocally Advanced Head and Neck CancerKuwait
-
Cairo UniversityUnknownLocally Advanced Head and Neck Cancer
-
Southern Europe New Drug OrganizationClinical Trial Unit Ente Ospedaliero CantonaleCompletedAdvanced Head and Neck Squamous Cancer
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Head, Neck and Chest CancerChina
-
Eastern Cooperative Oncology GroupCompleted
-
Radiation Therapy Oncology GroupGlaxoSmithKline; NovartisCompletedNon-HPV Locally Advanced Head and Neck CancerUnited States, Canada
-
Centre Jean PerrinGroupement Inter-Régional de Recherche Clinique et d'Innovation Auvergne...RecruitingLocally Advanced Head and Neck CarcinomaFrance
-
Jonsson Comprehensive Cancer CenterKate Farms IncRecruitingLocally Advanced Head and Neck CarcinomaUnited States
-
University of Alabama at BirminghamCompletedLocally Advanced Head and Neck CancerUnited States
Clinical Trials on Quality of Life Questionaires & Interview: EORTC QLQ C-30, EORTC QLQ H&N-35, Health Behaviors, Subjective Significance Questionnaire, Qualitative Assessment
-
Memorial Sloan Kettering Cancer CenterRecruitingHPV-Related Malignancy | Oropharynx Cancer | HPV-Related Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | HPVUnited States